Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Blasco

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Neuroimmunology|February 11, 2003
NFkappaB and AP-1 DNA binding activity in patients with multiple sclerosisN Flores, C Durán, M R Blasco, et al.
Journal of Neuroimmunology|October 12, 2000
Aminoguanidine reduces apoptosis of circulating V Beta 8.2 T lymphocytes in Lewis rats with actively induced experimental autoimmune encephalomyelitis. Association with persistent inflammation of the central nervous system and lack of recoveryC Puerta, I Martínez, P Baranda, et al.
Neurologia|January 17, 2018
Economic impact of the new oral treatments for multiple sclerosisL Álvarez Ayuso, B Rodríguez Marrodán, M R Blasco Quílez, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Neuroimmunology|February 11, 2003
NFkappaB and AP-1 DNA binding activity in patients with multiple sclerosisN Flores, C Durán, M R Blasco, et al.
Journal of Neuroimmunology|October 12, 2000
Aminoguanidine reduces apoptosis of circulating V Beta 8.2 T lymphocytes in Lewis rats with actively induced experimental autoimmune encephalomyelitis. Association with persistent inflammation of the central nervous system and lack of recoveryC Puerta, I Martínez, P Baranda, et al.
Neurologia|January 17, 2018
Economic impact of the new oral treatments for multiple sclerosisL Álvarez Ayuso, B Rodríguez Marrodán, M R Blasco Quílez, et al.
Pageof 2